-
IMRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Immuneering (IMRX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 45.21 mm | 45.21 mm | 45.21 mm | 45.21 mm | 45.21 mm | 45.21 mm |
Cash burn (monthly) | 4.84 mm | 1.90 mm | 5.09 mm | 5.15 mm | 4.49 mm | 4.36 mm |
Cash used (since last report) | 24.60 mm | 9.67 mm | 25.87 mm | 26.18 mm | 22.82 mm | 22.13 mm |
Cash remaining | 20.61 mm | 35.54 mm | 19.34 mm | 19.03 mm | 22.39 mm | 23.07 mm |
Runway (months of cash) | 4.3 | 18.7 | 3.8 | 3.7 | 5.0 | 5.3 |
13F holders | Current |
---|---|
Total holders | 40 |
Opened positions | 7 |
Closed positions | 27 |
Increased positions | 8 |
Reduced positions | 18 |
13F shares | Current |
---|---|
Total value | 8.84 bn |
Total shares | 7.13 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Merrin Investors | 2.77 mm | $8.03 mm |
Vanguard | 1.07 mm | $2.67 bn |
T. Rowe Price | 810.13 k | $2.02 mm |
MS Morgan Stanley | 449.31 k | $1.12 bn |
BlackRock | 318.42 k | $792.86 mm |
Millennium Management | 246.27 k | $613.21 mm |
Geode Capital Management | 209.64 k | $522.14 mm |
Southport Management, L.L.C. | 205.00 k | $510.45 mm |
Prosight Management | 190.00 k | $473.10 mm |
TD Asset Management | 150.88 k | $401.33 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | Michael Bookman | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 110,000 | 210.10 k | 110,000 |
5 Feb 25 | Benjamin J. Zeskind | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 480,000 | 916.80 k | 480,000 |
5 Feb 25 | Brett Matthew Hall | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 240,000 | 458.40 k | 240,000 |
5 Feb 25 | Harold Eugene Brakewood | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 100,000 | 191.00 k | 100,000 |
5 Feb 25 | Leah R Neufeld | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.91 | 110,000 | 210.10 k | 110,000 |